Although a large body of evidence points to Aβ as a central component contributing to AD pathogenesis, proteolytic fragments other than Aβ are also produced as a result of APP processing, including the APP intracellular domain (AICD), which gets released into the cytoplasm [10,11]. Here, APP is linked to Alzheimer disease.